Ca²⁺Channel α₂-δ Ligands for the Treatment of Neuropathic Pain

ADVERTISEMENT RETURN TO ISSUEPREVPerspectiveNEXTCa2+ Channel α2-δ Ligands for the Treatment of Neuropathic PainMark J. Field, Zheng Li, and Jacob B. SchwarzView Author Information Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48105, and Sandwich Laboratories, Sandwich, Kent CT13 9NJ, U.K. Cite this: J. Med. Chem. 2007, 50, 11, 2569–2575Publication Date (Web):May 10, 2007Publication History Received1 June 2006Published online10 May 2007Published inissue 1 May 2007https://pubs.acs.org/doi/10.1021/jm060650zhttps://doi.org/10.1021/jm060650zreview-articleACS PublicationsCopyright © 2007 American Chemical SocietyRequest reuse permissionsArticle Views1787Altmetric-Citations63LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Central nervous system,Monomers,Neurophysiology,Peptides and proteins,Rodent models Get e-Alerts